August 21, 2014

GlaxoSmithKline announced FDA approval for Arnuity Ellipta (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid medicine for the treatment of asthma in patients 12 years of age and older.

July 14, 2014

Teva Pharmaceuticals on Monday announced that the Food and Drug Administration has accepted the company's new drug application for albuterol multi-dose dry-powder inhaler, a breath-actuated dry-powder inhaler for the treatment or prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease.

May 9, 2014

Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, earlier this week announced that the Food and Drug Administration granted 510(k) clearance to market its latest generation of the Propeller platform, including a new sensor.

April 28, 2014

GlaxoSmithKline and Theravance on Monday announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), a once-daily that combines two long-acting bronchodilators in a single inhaler, is now available in retail pharmacies in the United States.

April 15, 2014

Prosonix, a speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by Design, on Tuesday announced that it has entered into a global licensing agreement with Mylan for its leading inhaled respiratory products, PSX1001 and PSX1050.

February 26, 2014

A pair of Food and Drug Administration advisory committees on Tuesday voted against the over-the-counter sale of Armstrong Pharmaceuticals' Primatene HFA, an epinephrine inhalation aerosol indicated for the temporary relief of mild symptoms of intermittent asthma for people ages 12 years or older.

February 18, 2014

The one-time $100 million asthma-relief brand Primatene may make a comeback to the marketplace after a more than two-year hiatus.

January 10, 2014

The Nonprescription Drugs Advisory Committee announced it would meet February 25 to discuss data submitted by Armstrong Pharmaceuticals in support of a new drug application for the over-the-counter marketing of Primatene HFA.

October 30, 2013

A once-daily inhaler for chronic obstructive pulmonary disease has become available, the makers of the inhaler said Wednesday.

October 23, 2013

The Food and Drug Administration plans to complete its phase out of inhalers that contain ozone-depleting chlorofluorocarbons by the end of the year, the agency said Wednesday.

September 10, 2013

A new set of guidelines from the Food and Drug Administration could bring a generic version of a respiratory drug made by GlaxoSmithKline closer to reality.

May 10, 2013

The Food and Drug Administration has approved a new treatment for chronic obstructive pulmonary disease, the agency said Friday.

May 1, 2013

Teva Pharmaceutical Industries has launched a generic inhaler used to treat bronchospasm, the company said.

April 22, 2013

Allermates today announced it is introducing EpiPen, Auvi-Q and asthma inhaler carrying cases.

April 17, 2013

A Food and Drug Administration panel has recommended that the agency approve an experimental drug for chronic obstructive pulmonary disease made by GlaxoSmithKline and Theravance, the two companies said.

January 3, 2013

An inhaler for patients with bronchospasm that includes a dose counter has become available from Teva Respiratory, the company said Thursday.

December 10, 2012

Several stores in the Giant Food Stores chain will collect used respiratory inhalers under a program sponsored by drug maker GlaxoSmithKline, the supermarket chain said.

October 24, 2012

Several cities across the country will play host to a new program from one drug maker to recycle respiratory inhalers.

September 12, 2012

GlaxoSmithKline is offering a recycling program for empty inhalers at retail pharmacies in 31 cities, the drug maker said Wednesday.

June 21, 2012

Homeopathic supplier King Bio currently is presenting a replacement alternative for patients still seeking relief for their minor asthma symptoms in its 
AsthmaCare product.


June 21, 2012

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention.

March 20, 2012

Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.

March 12, 2012

Melville, N.Y.-based Ascent Consumer Products late last month introduced a new delivery form to the nasal saline category — a dry salt inhaler branded InHalo — as a new solution to help break up mucous and promote nasal and bronchial drainage at the ECRM Cough & Cold and Allergy EPPS conference held here.

March 9, 2012

The Food and Drug Administration has approved a version of a drug made by Teva that includes a dose counter, the drug maker said.